HPV VIS Detail Information

> This page shows VIS [5000085] detail information, including site information (chromosome, GRCh38 location, disease, sample, etc) and literature information.


Site Information
DVID 5000085
VISID TVIS20005065
Chromosome chr14
GRCh38 Location 68125347, 68200909
Disease Uterine Cervical Neoplasms  
Sample Tumor
Virus Reference Genome Not given
Target Gene RAD51B  
Literature Information
PubMed PMID 24390348
Year 2014 Feb 20;506(7488):371-5
Journal Nature
Title Landscape of genomic alterations in cervical carcinomas.
Author Ojesina AI,Lichtenstein L,Freeman SS,Pedamallu CS,Imaz-Rosshandler I,Pugh TJ,Cherniack AD,Ambrogio L,Cibulskis K,Bertelsen B,Romero-Cordoba S,Trevino V,Vazquez-Santillan K,Guadarrama AS,Wright AA,Rosenberg MW,Duke F,Kaplan B,Wang R,Nickerson E,Walline HM,Lawrence MS,Stewart C,Carter SL,McKenna A,Rodriguez-Sanchez IP,Espinosa-Castilla M,Woie K,Bjorge L,Wik E,Halle MK,Hoivik EA,Krakstad C,Gabino NB,Gomez-Macias GS,Valdez-Chapa LD,Garza-Rodriguez ML,Maytorena G,Vazquez J,Rodea C,Cravioto A,Cortes ML,Greulich H,Crum CP,Neuberg DS,Hidalgo-Miranda A,Escareno CR,Akslen LA,Carey TE,Vintermyr OK,Gabriel SB,Barrera-Saldana HA,Melendez-Zajgla J,Getz G,Salvesen HB,Meyerson M
Evidence Cervical cancer is responsible for 10-15% of cancer-related deaths in women worldwide. The aetiological role of infection with high-risk human papilloma viruses (HPVs) in cervical carcinomas is well established. Previous studies have also implicated somatic mutations in PIK3CA, PTEN, TP53, STK11 and KRAS as well as several copy-number alterations in the pathogenesis of cervical carcinomas. Here we report whole-exome sequencing analysis of 115 cervical carcinoma-normal paired samples, transcriptome sequencing of 79 cases and whole-genome sequencing of 14 tumour-normal pairs. Previously unknown somatic mutations in 79 primary squamous cell carcinomas include recurrent E322K substitutions in the MAPK1 gene (8%), inactivating mutations in the HLA-B gene (9%), and mutations in EP300 (16%), FBXW7 (15%), NFE2L2 (4%), TP53 (5%) and ERBB2 (6%). We also observe somatic ELF3 (13%) and CBFB (8%) mutations in 24 adenocarcinomas. Squamous cell carcinomas have higher frequencies of somatic nucleotide substitutions occurring at cytosines preceded by thymines (Tp*C sites) than adenocarcinomas. Gene expression levels at HPV integration sites were statistically significantly higher in tumours with HPV integration compared with expression of the same genes in tumours without viral integration at the same site. These data demonstrate several recurrent genomic alterations in cervical carcinomas that suggest new strategies to combat this disease.

Contents
Description
  • Site Information
Detail information of site [5000085]
  • Literature Information
The details of literature that this site is associated with.